4-boronophenylalanine has been researched along with Osteogenic Sarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altieri, S; Bortolussi, S; Bruschi, P; Cansolino, L; Clerici, AM; Dionigi, P; Ferrari, C; Gaspari, A; Stella, S; Zonta, A; Zonta, C | 1 |
Arnopolskaya, AM; Khokhlov, VF; Kozlovskaya, NG; Kulakov, VN; Mitin, VN; Portnov, AA; Sheino, IN; Zaitsev, KN | 1 |
2 other study(ies) available for 4-boronophenylalanine and Osteogenic Sarcoma
Article | Year |
---|---|
Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
Topics: Animals; Biological Transport, Active; Bone Neoplasms; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Cell Survival; In Vitro Techniques; Isotopes; Male; Osteosarcoma; Phenylalanine; Radiation-Sensitizing Agents; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2009 |
Comparison of BNCT and GdNCT efficacy in treatment of canine cancer.
Topics: Animals; Bone Neoplasms; Boron Compounds; Boron Neutron Capture Therapy; Combined Modality Therapy; Dog Diseases; Dogs; Gadolinium; Humans; Melanoma; Mouth Neoplasms; Neoplasms; Neutron Capture Therapy; Osteosarcoma; Phenylalanine | 2009 |